Enstilar

Active Ingredient(s): Calcipotriene + Betamethasone Dipropionate
FDA Approved: * October 16, 2015
Pharm Company: * LEO PHARMA AS
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Enstilar Overview

Calcipotriol/betamethasone dipropionate (INNs; trade name Daivobet, Enstilar, among others) is a fixed combination of the synthetic vitamin D3 analog calcipotriol (also known as calcipotriene) and the synthetic corticosteroid betamethasone dipropionate for the treatment of plaque psoriasis in adults and adolescents (scalp only). It is used in the form of ointment, topical suspension, and foam. Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Pharmacology 4.1 Pharmacodynami...

Read more Enstilar Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Betamethasone/calcipotriol

Recent Enstilar Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Enstilar: (1 result)

Sorted by National Drug Code

• 50222-302 Enstilar Topical Aerosol, Foam by Leo Pharma Inc.

Drugs with one or more similar ingredients: (8 results)

• BETAMETHASONE DIPROPIONATE + CALCIPOTRIENE HYDRATE
• CALCIPOTRIENE + BETAMETHASONE DIPROPIONATE
• TACLONEX Betamethasone Dipropionate + Calcipotriene Hydrate
• TACLONEX SCALP Calcipotriene + Betamethasone Dipropionate
• CALCIPOTRIENE
• DOVONEX Calcipotriene
• SERNIVO Betamethasone Dipropionate
• SORILUX Calcipotriene